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Abstract – The objective of this work was to obtain transgenic tomato plants expressing the PfCP‑2.9 protein (a 
chimera of the antigens MSP1 and AMA1 of Plasmodium falciparum). Cotyledons of seven‑day‑old tomatoes, 
cultivar Summers, were transformed via Agrobacterium tumefaciens. Transgenic expression in the T0 plants 
was verified in the DNA extracted from fruits. PCR analysis was used to test the presence of the gene of interest 
in the T1 generation. Reverse transcriptase PCR provided evidence of gene expression at the RNA level, and 
Western blot analysis confirmed the presence of the protein of interest in the T1 plants. This is the first report 
of successful transformation with the expression of a malaria antigen (PfCP‑2.9) in transgenic tomato plants 
from the T0 and T1 generations.
Index terms: gene expression, genetic transformation, malaria, plant‑made vaccines.
Plantas transgênicas de tomate expressando o gene  
do antígeno PfCP‑2.9 de Plasmodium falciparum
Resumo – O objetivo deste trabalho foi obter plantas transgênicas de tomate que expressem a proteína 
PfCP‑2.9 (uma quimera dos antígenos MSP1 e AMA1 de Plasmodium falciparum). Cotilédones de tomate, 
cultivar Summers, com sete dias de idade, foram transformados via Agrobacterium tumefaciens. A expressão 
transgênica nas plantas T0 foi verificada no DNA extraído dos frutos. A análise por PCR foi utilizada para testar 
a presença do gene de interesse na geração T1. A evidência da expressão do gene no RNA foi constatada por 
meio da PCR de transcriptase reversa, e a análise “Western blot” confirmou a presença da proteína de interesse 
nas plantas T1. Este é o primeiro relato de transformação bem sucedida com a expressão de um antígeno da 
malária (PfCP‑2,9) em plantas transgênicas de tomate da geração T0 e T1.
Termos para indexação: expressão gênica, transformação genética, malária, vacina a partir de plantas.
Introduction
Malaria, a disease caused by protozoan parasites of 
the genus Plasmodium, is one of the world’s current 
biggest challenges (Chowdhury & Bagasra, 2007). 
Over 2 billion individuals reside in the malaria endemic 
areas, especially in the tropical countries, where this 
disease affects 300–500 million people annually (Patz 
et al., 2003). In fact, in 2004, Plasmodium falciparum 
was considered one of the leading causes of death 
worldwide, being induced by a single infectious agent 
(World Health Organization, 2009). Vaccines are a 
cost‑effective way of eradicating infectious diseases 
of this magnitude. However, the available malaria 
vaccines produced by conventional methods are still 
unaffordable for most people due to their high price, 
attributed to significant costs of fermentation and 
purification systems and other additional expenses 
associated with adjuvant, cold storage, transportation, 
and sterile delivery (Daniell et al., 2009). Therefore, 
there is an urgent need to find less expensive alternative 
methods to develop vaccines to combat malaria.
Pan et al. (2004) reported a potential malaria vaccine 
candidate, the PfCP‑2.9 protein produced through 
the fusion of the antigen MSP1‑19 with AMA‑1 (III). 
This vaccine candidate induces high production of 
antibodies in rabbits and monkeys, inhibiting the 
parasite development in the blood, as shown through 
in vitro studies. Peng et al. (2010) observed that the 
components of this chimeric protein did not change 
their structure after fusion, which indicates that this 
protein is a strong vaccine candidate in combating this 
disease.
There have been several reports of plant‑made 
vaccines or pharmaceuticals (Huang et al., 2005; 
Alvarez et al., 2006; Zhang et al., 2006). Arntzen et al. 
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(1996), for example, developed an edible vaccine, using 
transgenic tomatoes, against plague (Yersinia pestis). 
The immunogenicity of these transgenic tomatoes was 
confirmed in mice, which were primed subcutaneously 
with bacterially‑produced F1–V and boosted orally 
using transgenic tomato fruit. In another experiment, 
tomatoes expressed antigen genes encoding HBsAg, 
HIV gag, and Rabies capsid proteins (Sala et al., 2003). 
Additionally, the Norwalk virus capsid protein produced 
in transgenic tomatoes showed immunogenicity in mice 
when the transgenic freeze‑dried tomato was orally 
delivered (Huang et al., 2005).
Turpen et al. (1995) were the first to report the 
expression of a malaria antigen in the tobacco plant. 
Recently published works indicate the expression 
of antigens against malaria in lettuce and tobacco 
(Davoodi‑semiromi et al., 2010), Arabidopsis thaliana 
seeds (Lau et al., 2010), and green algae (Dauvillée 
et al., 2010). The malaria antigens used were AMA1, 
MSP1 (Dauvillee et al., 2010; Davoodi‑semiromi et al., 
2010), and MSP142 (Lau et al., 2010).
The production of an edible vaccine in tomato plants 
could prevent the development of malaria parasites by 
activating the entire immune system mechanism, which, 
consequently, would interfere with the malaria parasite 
from one life stage to another (Chowdhury et al., 2009). 
Since the tomato is a very popular vegetable in malaria 
endemic areas, such as Africa and Asia, edible vaccines 
expressed in tomatoes would represent an effective, 
safe, and inexpensive way of vaccination (Chowdhury 
& Kantor, 2008; Chowdhury et al., 2009).
The objective of this work was to obtain transgenic 
tomato plants expressing the PfCP‑2.9 protein 
(a chimera of the antigens MSP1 and AMA1 of 
Plasmodium falciparum).
Materials and Methods
The Summers tomato variety was used for the 
transformation experiment via Agrobacterium 
(Wang, 2006). The Plasmodium gene of interest 
(PfCP‑2.9=1036bp) was codon optimized and 
synthesized by GenScript (GenScript – Transforming 
Biology Research, Piscataway, NJ, USA) for expression 
in tomato. The PfCP‑2.9 DNA was then cloned in the 
pPS1 plant transformation vector, and the plasmid 
was introduced in the Agrobacterium strain LBA 4404 
through electroporation (Seidman et al., 2001). Two 
Agrobacterium colonies were obtained after the process 
of electroporation. After performing PCR, only one 
colony presented both genes of interest, PfCP‑2.9 and 
nptII (kanamycin resistance determinant). This colony 
was resuspended in liquid Murashige & Skoog medium 
(Murashige & Skoog, 1962), and the optical density 
was adjusted to 0.4 cells mL‑1. Seven‑day‑old tomato 
cotyledons were transferred to the Agrobacterium 
suspension containing 100 µmol L‑1 acetosyringone 
and incubated at room temperature for 20 min.
The cotyledons were then blotted dry using sterile 
filter paper, transferred to solid MS medium as described 
by Velcheva et al. (2005), without acetosyringone, 
and incubated in a dark growth chamber at 23oC. 
After co‑cultivation for 72 hours, the explants were 
transferred to the MS selection medium containing 
300 mg L‑1 ticarcillin (timentin) and 50 mg L‑1 
kanamycin, for four weeks, followed by transfer to the 
same selection medium containing 400 mg L‑1 timentin 
and 100 mg L‑1 kanamycin, for another eight weeks. 
The DNAs of putative transformants were analyzed by 
the PCR method. A total number of three transformed 
plants (plant 1, 2, and 3) with the PfCP‑2.9 gene 
reached maturity and produced fruit. Ripe tomato 
fruits were harvested as they reached maturity. Seven 
fruits were harvested from plant 1, 36 fruits from 
plant 2, and nine fruits from plant 3.
DNA was extracted from the ripe fruits of 
transformed (T0) plants. The seeds harvested from 
the tomato transgenic plants were germinated, and the 
DNA was isolated from the cotyledons of each plant 
source by the CTAB method (Ausubel et al., 1994). 
The DNA samples were tested for the presence of the 
gene of interest using the PCR method. Additionally, 
DNA was extracted from the hypocotyledons of 
plant 2 and tested. After DNA amplification using the 
PCR method, samples were analyzed by agarose gel 
electrophoresis.
The following primers were chosen for 
the detection of the nptII gene: Forward: 
5’‑GAGGCTATTCGGCTATGACTG‑3’ and Reverse: 
5’‑ATCGGGAGCGGCGATACGTA‑3’. The primers 
used for the detection of the PfCP‑2.9 malaria gene 
were: Forward: 5’‑ATACAAAACAAACGAATCTC‑3’ 
and Reverse: 5’‑GGAGTGTCTTAGGTGACTTA‑3’. 
Both sets of primers were synthesized by Eurofins 
(Eurofins MWG Operon, Huntsville, AL, USA). The 
PCR program steps were: initialization at 94oC for 
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4 min, followed by denaturation at 94oC for 1 min, 
then by annealing temperature at 50oC for 1 min and 
elongation temperature at 72oC for 1 min. The final 
extension was performed at 72oC for 10 min. The 
cycles were repeated 30 times.
After identifying the presence of the gene of interest 
in the DNA extracted from the first generation of 
transformed plants, the next step was to demonstrate 
that the gene of interest was successfully integrated 
into the plant genome. Since DNA testing is not enough 
to determine the functionality and the successful 
integration of PfCP‑2.9 into the plant genome, 
reverse transcriptase PCR (RT‑PCR) was performed. 
The RT‑PCR method is commonly used for a rapid 
identification and expression of the gene of interest in 
the transgenic plants genome (Huang et al., 2011). For 
this experiment, seeds from plants 1, 2, and 3 of the 
T0 generation were germinated and RNA was extracted 
from the leaves of one young plantlet representing 
each plant. The Aqua Pure RNA isolation kit (Bio‑Rad, 
Hercules, CA, USA) was used for this procedure. For 
cDNA synthesis, the following program steps were 
used: 5 min at 15oC, followed by 30 min at 42oC and 
another 5 min at 85oC. The PCR amplification program 
was the same as the one used for DNA amplification.
The Bradford method (Bradford, 1976) and the 
plant protein extraction kit (Sigma‑Aldrich, St. Louis, 
MO, USA) were used to quantify the protein extracted 
from fresh cotyledons of the T1 plants.  Different 
dilutions of 2 mg mL‑1 BSA were used to develop the 
standard curve, and the concentrations of unknown 
protein samples were determined by comparison to 
the standard curve. The device used for reading the 
values was a Multiskan Ex ELISA reader (Thermo 
Fisher Scientific, Hudson, NH, USA), and the data 
was interpreted with the Ascent software, version 2.6 
(Thermo Fisher Scientific, Hudson, NH, USA). The 
amounts of proteins extracted from tomato fruits were 
much lower than the quantities obtained from leaves. 
As a consequence, the protein extracted from leaves 
was used for the Western blot experiment.
The polyacrylamide gel was analyzed with the 
Western blot method. Due to the absence of purified 
antibodies against the PfCP‑2.9, the antibody against 
AMA1 (which is part of PfCP‑2.9) was used to 
test the total soluble protein (TSP) extracted from 
leaves. The Western blot experiment was performed 
using the protocol described in the Mini Trans‑Blot 
electrophoretic transfer cell instruction manual 
(Bio‑Rad, Hercules, CA, USA) with a few changes, 
including current intensity or concentration of 
antibodies. Modifications to the protocol regarding 
antibody concentrations were performed according 
to Alvarez et al. (2006). Samples from leaves of 
the T1 transformed plants with the PfCP‑2.9 gene, 
representing all four plants of the T0 generation, were 
analyzed in duplicate and subjected to migration in 
two acrylamide gels, one for protein identification and 
the other for use in the Western blot experiment. The 
proteins were transferred from the acrylamide gels to 
polyvinylidene difluoride (PVDF) membrane using a 
Mini Trans‑Blot apparatus electrophoretic transfer cell 
catalog #170‑3930, (Bio‑Rad, Hercules, CA, USA).
Primary antibodies were diluted (1:2000) in TTBS 
(Tris‑buffered saline with 0.05% Tween 20), and a total 
volume of 60 mL was prepared for each membrane. 
The next step consisted of the dilution of secondary 
antibodies goat anti‑rabbit HRP conjugate, (Bio‑Rad, 
Hercules, CA, USA) in TTBS using a 1:10000 dilution. 
The membranes were then washed with TTBS six times 
after removing the antibody solution. After using the 
electrophoretic method to transfer proteins from the gel 
on the PVDF membrane, the presence of the protein of 
interest was recorded with a Kodak Gel Logic 1500 
imaging system camera. No positive controls were 
observed due to the absence of the purified PfCP‑2.9 
protein. 
Results and Discussion
Three transgenic (T0) tomato plants from a total 
number of 336 explants (0.89% regeneration rate) 
reached maturity and produced fruit and seeds. The 
obtained regeneration rate is lower than the one 
reported by Velcheva et al. (2005), who found a rate 
between 1.4 and 34%.
All plants transformed with the gene of interest 
PfCP‑2.9 showed DNA bands when tested for the 
presence of the malaria antigen gene (Figure 1 A). 
The size of the observed DNA bands was 1,036 bp 
for the PfCP‑2.9 gene and 700 bp for the nptII gene 
(Van Den Broeck et al., 1985), whereas the negative 
control showed no band (Figure 1 A and B). The 
successful expression of malaria antigens, such as 
AMA1 and MSP1, was reported in lettuce and tobacco 
(Davoodi‑semiromi et al., 2010). However, these genes 
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were individually introduced. In the present study, the 
PfCP‑2.9 gene introduced in tomatoes is a fused product 
of part of the previously mentioned genes, which is far 
superior as to immunogenicity (Pan et al., 2004). For 
example, in rabbits and monkeys, PfCP‑2.9 produces 
a chimeric protein that initially appeared to be highly 
immunogenic. Since the anti‑AMA‑1(III) antibody 
titer induced by PfCP‑2.9 was 18‑fold higher than that 
induced by AMA‑1(III), and the anti‑MSP1‑19 antibody 
titer was 11‑fold higher than that induced by MSP1‑19 
(Pan et al., 2004), it was suggested that PfCP‑2.9 in 
combination with these recombinant pre‑erythrocytic 
antigens induces the production of antibodies that inhibit 
growth of blood‑stage malarial parasites.
All samples tested for DNA extracted from the first 
generation of transformed plants (T1) showed the 
bands corresponding to both genes of interest (nptII 
and PfCP‑2.9) (Figure 2). This is the first report of 
the successful expression of the malaria antigen gene 
in the T1 generation of transgenic tomato plants, 
indicating the stable integration of the PfCP‑2.9 gene 
Figure 1. DNA from ripened tomato fruits tested for the 
presence of the nptII gene and the PfCP‑2.9 malaria gene. 
A, 1,036 bp band corresponding to the PfCP‑2.9 gene (right 
side) in all plants tested, and band corresponding to the nptII 
gene (left side) only in plant 1; B, 700 bp band corresponding 
to the nptII gene found when the DNA extracted from plants 
2 and 3 was retested.
in the tomato genome and its transmission to the next 
generation through seed production. Lau & Korban 
(2009) found similar results of integration, stability, and 
transmission of the respiratory syncytial virus antigen in 
the T3 generation of transgenic tomato plants.
RNA extracted from the three transformed plants 
was tested, and all plants were confirmed positive 
with the detection of an expected 1,036 bp fragment, 
whereas the negative control had no target band 
(Figure 3). The presence of the PfCP‑2.9 gene was 
confirmed in the DNA extracted from the transgenic 
plants, as well in the plant RNA, illustrating the 
successful integration and expression of the target 
gene in transformed plants. The integration of foreign 
DNA in a plant genome is the first step of transgene 
expression. However, to confirm gene expression, it is 
important to determine RNA production for the gene 
of interest in the transgenic plant. In the present study, 
all three plants showed RNA synthesis. Similar results 
of RNA expression were found in transgenic tomato 
plants producing chimeric protein T and B cell epitope, 
containing immunogenic (TBI) hepatitis B surface 
antigen (HBSAg), as reported by Salyaev et al. (2005).
So far, current studies have permitted the 
quantification of total proteins extracted from leaves of 
Figure 2. Gel showing the 700 bp band corresponding to the 
nptII gene (left side) and the 1,036 bp band corresponding to 
the PfCP‑2.9 malaria gene (right side), in first generation of 
transgenic tomato.
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T1 plants. The largest amount of total soluble protein 
(17.5 µg mL‑1 of TSP) was extracted from plant 3 of 
the Summers tomato variety, transformed with the 
PfCP‑2.9 gene (Table 1). The obtained TSP amount 
corresponds to 35 mg of TSP per gram of fresh leaf. 
The TSP extracted from the tomato leaves is similar 
to that obtained by other researchers (Biswas et al., 
2012). When TSP was analyzed using the Western blot 
method, only one (plant 1) out of the three transformed 
plants with the PfCP‑2.9 gene showed a protein band 
of 32.5 kDa (Figure 4), which is the same size protein 
as that reported by Zhang et al. (2007) when the 
PfCP‑2.9 gene was expressed in Pichia pastoris.
Figure 3. Gel showing the 1,036 bp cDNA synthesized from 
mRNA isolated from the first generation of tomato plants 
transformed with the PfCP‑2.9 gene.
Table 1. Protein concentrations extracted from fresh leaves 
of transformed 'Summers' tomato plants(1).
Transformed plants 
with the PfCP‑2.9 gene
O.D.600 values 
(cells mL‑1)
TSP  
(µg mL‑1)
Leaf  
weight  (mg)
TSP  
content (mg g‑1) 
Plant 1, sample 1 0.134/0.133 11.1605 26 22.321
Plant 1, sample 2 0.109/0.1 5.6935 32 11.387
Plant 2, sample 1 0.122/0.124 9.1815 55 18.363
Plant 2, sample 2 0.138/0.133 11.5375 15 23.075
Plant 3, sample 1 0.166/0.104 11.443 27 22.886
Plant 3, sample 2 0.154/0.181 17.5 29 35
(1)O.D., optical density; TSP, total soluble protein.
Figure 4. Protein gel showing the chimeric PfCP‑2.9 
protein identified in total protein extracted from first the 
generation of transgenic tomato leaf hybridized with 
AMA‑1 monoclonal antibody.
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Conclusions
1. Tomato plants transformed with the PfCP‑2.9 gene 
express the malaria antigen gene in tomato fruit.
2. The gene PfCP‑2.9 is transferred to the next 
generation of tomato plants. 
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